NEUROVISION IMAGING LLC has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets medical technology, computer technology and optics are INNON HOLDINGS LLC, DURELL & GITELIS INC and APERTURE DIAGNOSTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | Israel | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Computer technology | |
#3 | Optics |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Healthcare informatics | |
#3 | Image data processing | |
#4 | Optical systems | |
#5 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Verdooner Steven | 14 |
#2 | Blanco Austin | 7 |
#3 | Biggs David | 7 |
#4 | Verdooner Steven Roger | 4 |
#5 | Steven Verdooner | 3 |
#6 | Sparks Rodney | 2 |
Publication | Filing date | Title |
---|---|---|
US2017319063A1 | Apparatus and method for recording and analysing lapses in memory and function | |
US2016206199A1 | System and method for rejecting afocal light collected from an in vivo human retina | |
US2014268049A1 | Method for detecting a disease by analysis of retinal vasculature | |
EP2967327A1 | Method for detecting amyloid beta plaques and drusen | |
US2014176908A1 | Apparatus to detect amyloid in a patient user's retina in a diagnosis, advancement and prognosis of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative disorders and ocular diseases | |
MX2013004317A | Apparatus and method for detecting amyloid in a retina in a diagnosis, advancement, and prognosing of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative dissorders, and ocular diseases. |